Lukas Scheibler

(Dr. Lukas Scheibler Ph.D.)

Currently holds a position at Apellis Pharmaceuticals Inc

Positions
Position Company Period
Chief Innovation Officer Apellis Pharmaceuticals Inc April 1, 2019 -
Executive Vice President - Research and Development Apellis Pharmaceuticals Inc April 1, 2018 - April 1, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-09-07 2023-09-06
S Sale
1,756 -2.5%
43.01
75,526 USD 		1,756 -2.5% 43.01 75,526 USD
2022-05-31 2022-05-27
PS Planned sale
10,000 -19.9%
43.00
430,000 USD 		10,000 -19.9% 43.00 430,000 USD
2022-04-06 2022-04-05
PS Planned sale
609 -1.2%
60.09
36,593 USD 		609 -1.2% 60.09 36,593 USD
2022-04-05 2022-04-04
PS Planned sale
1,249 -2.3%
57.81
72,198 USD 		1,249 -2.3% 57.81 72,198 USD
2022-04-05 2022-04-04
PS Planned sale
1,437 -2.6%
56.86
81,714 USD 		1,437 -2.6% 56.86 81,714 USD
2022-04-05 2022-04-04
PS Planned sale
818 -1.5%
55.84
45,677 USD 		818 -1.5% 55.84 45,677 USD
2022-04-04 2022-04-01
PS Planned sale
11,496 -18.0%
55.05
632,855 USD 		11,496 -18.0% 55.05 632,855 USD
2022-02-14 2022-02-11
PS Planned sale
1,666 -3.1%
46.80
77,969 USD 		1,666 -3.1% 46.80 77,969 USD
2022-02-14 2022-02-10
PS Planned sale
10,000 -15.8%
50.00
500,000 USD 		10,000 -15.8% 50.00 500,000 USD
2022-02-10 2022-02-08
PS Planned sale
10,000 -15.7%
45.00
450,000 USD 		10,000 -15.7% 45.00 450,000 USD
2022-02-01 2022-01-31
PS Planned sale
1,233 -2.2%
38.47
47,434 USD 		1,233 -2.2% 38.47 47,434 USD
2021-06-11 2021-06-10
PS Planned sale
3,417 -11.4%
60.00
205,020 USD 		3,417 -11.4% 60.00 205,020 USD